MicroRNAs in C. elegans Aging: Molecular Insurance for Robustness? by Ibáñez-Ventoso, Carolina & Driscoll, Monica
144  Current Genomics, 2009, 10, 144-153   
   1389-2029/09 $55.00+.00  ©2009 Bentham Science Publishers Ltd. 
MicroRNAs in C. elegans Aging: Molecular Insurance for Robustness? 
Carolina Ibáñez-Ventoso and Monica Driscoll* 
Department of Molecular Biology & Biochemistry, Rutgers, The State University of New Jersey, A232 Nelson Biological 
Laboratories, 604 Allison Road, Piscataway, New Jersey 08854, USA 
Abstract: The last decade has witnessed a revolution in our appreciation of the extensive regulatory gene expression 
networks modulated by small untranslated RNAs. microRNAs (miRNAs), ~22 nt RNAs that bind imperfectly to partially 
homologous sites on target mRNAs to regulate transcript expression, are now known to influence a broad range of bio-
logical processes germane to development, homeostatic regulation and disease. It has been proposed that miRNAs ensure 
biological robustness, and aging has been described as a progressive loss of system and cellular robustness, but relatively 
little work to date has addressed roles of miRNAs in longevity and healthspan (the period of youthful vigor and disease 
resistance that precedes debilitating decline in basic functions). The C. elegans model is highly suitable for testing hy-
potheses regarding miRNA impact on aging biology: the lifespan of the animal is approximately three weeks, there exist 
a wealth of genetic mutations that alter lifespan through characterized pathways, biomarkers that report strong healthspan 
have been defined, and many miRNA genes have been identified, expression-profiled, and knocked out. 50/114 C.  
elegans miRNAs change in abundance during adult life, suggesting significant potential to modulate healthspan and 
lifespan. Indeed, miRNA lin-4 has been elegantly shown to influence lifespan and healthspan via its lin-14 mRNA target 
and the insulin signaling pathway. 27 of the C. elegans age-regulated miRNAs have sequence similarity with both fly and 
human miRNAs. We review current understanding of a field poised to reveal major insights into potentially conserved 
miRNA-regulated networks that modulate aging. 
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INTRODUCTION 
  microRNAs (miRNAs) are short non-translated RNAs 
(~22nt) that regulate post-transcriptional gene expression via 
antisense base pairing to partially complementary sites in   
the 3’ UTRs (primarily) of messenger RNAs (mRNAs).   
miRNAs downregulate protein expression by inhibiting 
mRNA translation and/or mRNA stability, although induc-
tion of rapid degradation of nascent peptides has also been 
proposed as a regulatory mechanism [1], and there is at least 
one reported case of translational upregulation by compo-
nents of the miRNA machinery [2]. Individual miRNAs can 
modulate multiple mRNA targets, and individual mRNAs 
can be regulated by multiple, distinct miRNAs. The picture 
that emerges is one of highly complex regulatory networks 
that control batteries of gene targets. Of the thousands of 
miRNAs catalogued in the miRNA repository miRBase [3-
5], functional characterization of a small fraction supports 
the participation of miRNAs in a broad range of biological 
processes, including cell proliferation, morphogenesis, cell 
differentiation, metabolism, immunity, stress response, sig-
nalling, cell death, cancer and age-related disease such as 
neurodegeneration. More recently, several groups have 
turned to consider the possible roles of miRNAs in the biol-
ogy of aging. Here we review initial efforts in this direction  
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in the powerful C. elegans model, which holds distinct ad-
vantages for experimentally addressing the importance of 
miRNAs in genetic modulation of longevity and healthspan. 
Caenorhabditis elegans AS A MODEL SYSTEM FOR 
STUDYING ROLES OF MicroRNAS IN AGING AND 
HEALTHSPAN 
 The  nematode  C. elegans is a genetically tractable model 
organism of uniform genetic background that has been ex-
tensively used in the study of aging and longevity to identify 
genes that impact these processes. This small (1mm long) 
transparent animal develops in ~ 3 days through a reproduci-
ble set of fully documented cell divisions to generate a sexu-
ally mature adult of 959 somatic cells. C. elegans somatic 
cells do not undergo any regenerative cell divisions and de-
velopmental cell divisions are completed during larval de-
velopment. Thus, the aging biology of this animal best mod-
els the situation in mammalian tissues that do not divide to 
replenish or repair cells. The average C. elegans lifespan is 
about 21 days under standard lab conditions (abundant food, 
20
oC), although lifespan can be dramatically changed by 
environmental factors such as low temperature growth or 
food limitation (dietary restriction). Notably, there is a con-
siderable degree of variation in mean and maximum lifespan 
within a genetically uniform population reared under the 
same conditions, indicating that stochastic factors have a 
significant impact on healthspan and lifespan [6]. 
  In the lab at 20
oC, C. elegans life can be described as 
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(egg through 4 larval stages, about 3.5 days); 2) the repro-
ductive period (reproduction by self-fertilization occurs for 
the first 5-6 days of adult life until sperm supplies are ex-
hausted, although mating can result in additional progeny 
production even fairly late in life [7]); and 3) a post-
reproductive phase (~two weeks). It is striking that the de-
cline over adult life bears many features of aging in other 
animals, many of which live considerably longer. This sug-
gests that similar processes and mechanisms modulate age-
associated decline across phyla [8]. For example, C. elegans 
locomotory behaviors of crawling on plates or swimming in 
liquid decline in vigor with age. This decline is correlated 
with physical deterioration of the bodywall muscle cells in a 
manner that closely resembles human sarcopenia [6], a con-
dition of progressive loss of muscle mass and muscle 
strength that begins with mid-life onset and progresses to be 
highly debilitating at advanced age [9, 10]. Pumping of the 
pharyngeal muscle, proposed to be analogous to cardiac 
muscle, also becomes progressively slower and erratic with 
age [11, 12]. As in mammalian non-dividing cells, autofluo-
rescent advanced glycation end (AGE) products and lipofus-
cin accumulate with age [13, 14]. These age pigments are a 
heterogeneous mix of cross-linked proteins, lipids and nu-
cleic acids altered by attached reactive sugars that have been 
proposed to impair lysosomal function. In C. elegans low 
age pigment accumulation is correlated with "graceful" aging 
and extended healthspan and lifespan; conversely, high age 
pigments are correlated with physiologically aged, decrepit 
animals [14]. The point to be made here is that in the nema-
tode model, there are several biomarkers that reflect the 
quality of aging, and these can be measured to identify ani-
mals that age better than others. 
  More than 300 genetic manipulations in C. elegans have 
been reported to affect lifespan [15], a clear demonstration 
that genes influence longevity. A major pathway impacting 
C. elegans lifespan and healthspan is a conserved insu-
lin/IGF-like signal transduction pathway that was first char-
acterized for its role in formation of dauer larvae under ad-
verse growth conditions. Reduction-of-function mutations in 
the daf-2 insulin/IGF-1 receptor and downstream signaling 
kinases can confer longevity [16-19] by releasing DAF-
16/FOXO transcription factor from inhibitory phosphoryla-
tion to activate beneficial transcription [20-23]. In addition 
to genes regulating insulin signaling, genes influencing de-
velopmental timing, sensory signaling, mitochondrial func-
tion, and dietary restriction can significantly alter C. elegans 
lifespan [24]. Mutations affecting specific processes can be 
combined in double mutants to produce additive effects on 
longevity. Record mean and maximum longevity (~ 10X) 
has been reported for null mutants of age-1 PI3 kinase [25], 
but standard lifespan extension of single gene mutations is 
more commonly on the order of 20-50%. In general, research 
has focused on mutations or RNAi knockdowns that confer 
lifespan extension rather than short life, because of the chal-
lenges of unambiguously distinguishing sickness from early 
aging. Recent studies that better define healthspan and aging 
indicators such as locomotion decline [6, 11, 26], accumula-
tion of lipofuscin and age pigments [13, 14], pharyngeal 
pumping [11, 12], and even gene expression profiling [27], 
now make it easier to distinguish nematode progeria (accel-
erated aging). Given the short lifespan, multiple indicators of 
healthy aging, and a wealth of available genetic reagents, the 
C. elegans model appears optimally poised to be exploited to 
address roles of miRNAs on lifespan and healthspan. 
A Snapshot View of the microRNAs from a Model Or-
ganism 
  According to the current annotation of miRBase (release 
12.0), there are 154 identified C. elegans miRNA genes that 
encode sequences with characteristic miRNA precursor fea-
tures (one strand with the potential to encode imperfectly 
base-paired hairpin structures that can be processed into ~22 
nt mature miRNA [28]). Given that the C. elegans genome 
sequence has been exhaustively analyzed for potential mir 
genes, and that extensive deep sequencing has been reported 
for this animal [29, 30], it is likely that the current list repre-
sents nearly all of the miRNAs expressed under standard 
growth conditions. Although more C. elegans mir genes may 
be discovered by biochemical approaches (as in ref. [31]), or 
in deep sequencing studies under specific growth regimens, 
the current list is likely to constitute a fairly accurate over-
view of the miRNA content of an entire organism under the 
conditions in which most experimental investigations are 
conducted. 
  What does a genome-wide overview of miRNAs reveal 
with regard to numbers of distinct miRNA families and their 
potential for functional redundancy? We evaluated  all se-
quence relationships of mature C. elegans miRNAs in miR-
Base release 10.1 [32]. We classified miRNAs as potentially 
functionally redundant based on 5’ end “seed” sequence 
similarity and/or 70% similarity extended over the full (~22 
nt) mature sequence because miRNAs related by either of 
these criteria have been experimentally demonstrated to have 
functional redundancy [33-36]. In general, ~60% of C. ele-
gans miRNAs share significant sequence similarities with 
distinct miRNAs encoded elsewhere within the nematode 
genome. These sequence relationships suggest considerable 
potential for functional redundancy within families, although 
evaluation of physiological redundancy requires addressing 
the question of whether related miRNAs are co-expressed in 
the same cell types at the same time, a project well underway 
[37]. One important consequence of potential functional re-
dundancy among miRNAs is that genetic knockouts of indi-
vidual  mir  genes may not suffice to reveal the biological 
function of a given family. Indeed, elegantly studied exam-
ples of miRNA functional redundancy have been published 
for the role of the let-7 family members in regulating timing 
of developmental processes [33, 36]. The potential for func-
tional redundancy may partially explain the general observa-
tion from evaluation of 92 genetic knockouts of C. elegans 
mir genes that most individual mir deletions do not confer 
readily apparent phenotypes under standard growth condi-
tions [38]. Thus, studies that evaluate aging phenotypes in 
mir mutants will need to take potential functional redun-
dancy into consideration. 
Many  C. elegans microRNAs are Conserved Across   
Species 
  Another important question germane to use of genetic 
models to inform on miRNA functions in the biology of ag-
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be conserved in evolution. miRNAs pose interesting prob-
lems in evolutionary biology because sequences need to be 
maintained in both the miRNA as well as in the critical tar-
get transcripts; miRNAs standardly modulate expression of 
multiple targets, adding to potential constraints [39]. This 
being said, sequence conservation of miRNAs across species 
is considerable. In miRBase 10.1, ~62% of C. elegans  
miRNAs are related to Drosophila miRNAs and ~55% of C. 
elegans miRNAs are related to human miRNAs—more than 
half of C. elegans miRNAs have common sequences in both 
flies and humans [32]. This extensive conservation suggests 
that miRNAs could exert common functional roles across 
phyla. One striking example of such a case is let-7 family 
regulation of RAS oncogene expression. C. elegans let-7 
miRNA regulates the timing of fate differentiation of mul-
tipotent seam cells during C. elegans development [40], and 
sequence-related miRNAs let-7 and miR-84 have been 
shown to negatively regulate C. elegans RAS gene let-60, 
which contributes to developmental signaling [36]. In hu-
mans, let-7 family mir genes are poorly expressed in a range 
of malignancies including lung cancer [41, 42]. In vitro, hu-
man  let-7 has been shown to down-regulate expression of 
RAS protein and over-expression of let-7 inhibits the growth 
of human lung cancer cells [36, 42]. Recent over-expression 
studies in a mouse K-RAS lung cancer model demonstrated 
tumor suppressor function for let-7 in vivo [43], a result with 
clear therapeutic implications. Thus, dissection of basic biol-
ogy of a miRNA family in an experimentally accessible 
model can inform on conserved functions. Whether this will 
be true in the biology of aging remains to be tested. 
  Overall, however, the C. elegans model, with the pleth-
ora of molecular and genetic manipulations that can be exe-
cuted, the comprehensive identification of conserved   
miRNAs that has been accomplished [32], the wealth of 
available miRNA deletion mutants [38], records of spatio-
temporal expression patterns for many canonical miRNAs 
[37, 44-47], and the computational predictions of miRNA 
targets [48] within a well annotated genome [78] (which can 
be complemented with target predictions in the nematode 
using other algorithms [5, 30, 49-53]), is a powerful experi-
mental vehicle for deciphering functions that might apply to 
the understanding of miRNA functions in aging organisms. 
C. elegans MicroRNAS CHANGE EXTENSIVELY IN 
ABUNDANCE DURING ADULT LIFE 
  How miRNAs might regulate healthspan and lifespan is a 
question that is just coming into focus and is likely to remain 
at the forefront of aging research for some time. As a first 
step toward understanding how miRNAs might impact ag-
ing, we documented how miRNAs change in abundance dur-
ing adult C. elegans life [48], the first whole-organism 
miRNA profiling accomplished for aging animals. We iso-
lated small RNAs from aging C. elegans adults and detected 
expression levels of the 114 C. elegans miRNAs registered 
in miRBase 5.0 via  microarray hybridization [54]. The C. 
elegans strain used for this analysis was rendered sterile by a 
temperature-sensitive fertility mutation so that age-synchron- 
ized cultures could be easily maintained. Fig. (1A) depicts 
sampling time points relative to the lifespan curve. For each 
age, we normalized miRNA levels to levels in day4 first-day 
adult animals and plotted values over time. Fig. (1B) gives 
an example of how conserved miRNAs let-7, lin-4 and miR-
1 change over adult C. elegans life. 
  Of the 114 miRNAs screened, we found that 50 change 
in expression during adulthood with a 90% confidence statis-
tic--we refer to these 50 as age-regulated miRNAs. 34 of 
these age-regulated miRNAs fell within a 95% confidence 
level. Nearly two thirds (31) varied more than twofold be-
tween maximum and minimum expression levels over adult 
life. In terms of expression patterns, we did not note a clear 
correlation in the expression of age-regulated miR family 
members or in that of age-regulated miRNAs clustered in the 
genome—in some cases family members or clustered mir 
genes appear to have similar expression patterns, but in 
many they do not. 
  It is probably worth emphasizing that this C. elegans 
study provides an indication of how whole-body levels of 
individual miRNAs vary on average, but that miRNAs that 
change in only a few cells, or miRNAs that change recipro-
cally in different tissues could be missed in this analysis. 
Thus, there is likely even more extensive modulation of 
miRNA levels during aging than appears from this first gen-
eral survey. Nevertheless, one certain conclusion emerges: 
there are substantial changes in levels of many miRNAs   
during adult C. elegans life. As such, these age-regulated   
miRNAs are candidate modulators of aging and longevity. 
CONSERVED AGE-REGULATED MicroRNAs 
  Interestingly, of the 50 miRNAs that significantly change 
in expression during C. elegans adulthood, 27 share se-
quence conservation with human miRNAs (Table 1; refer to 
[32] for details of sequence relationships). Several of these 
(for example, let-7, miR-1, miR-34) have been investigated 
for roles in biology apart from aging. Which age-regulated 
miRNAs influence aging in nematodes, flies and/or humans 
remains mostly to be experimentally determined. Given that 
conserved mechanisms such as insulin signaling, dietary 
 
Table 1.  Conserved Age-Regulated MicroRNAs 
let-7 
5’ 70  miR-54 
5’   miR-81 
5’  
lin-4 
5’ 70  miR-56 
5’   miR-82 
5’  
miR-1 
5’ 70   miR-57 
5’ 70   miR-228 
5’ 70  
miR-2 
5’   miR-58 
5’   miR-229 
5’  
miR-34 
5’ 70   miR-63 
5’   miR-231 
5’  
miR-43 
5’   miR-64 
5’   miR-241 
5’  
miR-45 
5’   miR-65 
5’   miR-251 
5’  
miR-50 
5’ 70   miR-73 
5’   miR-268 
5’  
miR-51 
5’ 70   miR-74 
5’   miR-273 
5’  
27 C. elegans age-regulated miRNAs have conserved sequences in humans, 
and all of these are also conserved to some extent in Drosophila mela-
nogaster. Detailed sequence relationships are described in [32].  indicates 
miRNAs for which deletion alleles are available; mutant strains carrying 
point mutations are also available for miRNAs let-7 and lin-4 [77]. Super-
script numbers inform on the degree of miRNA sequence conservation. 5’: 
sequence homology mostly restricted to the 5’ end, 70: 70% sequence 
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restriction and oxidative stress responses impact both 
lifespan and healthspan across phyla, it is plausible that func-
tional studies of conserved miRNAs in facile invertebrate 
models could identify a novel set of small molecule modula-
tors of universal components of aging. 
DO PATTERNS OF MicroRNA CHANGES REVEAL 
COMPONENTS OF AGING BIOLOGY? 
  We found that miRNA expression levels varied in a 
range of pattern types during C. elegans adulthood. Interest-
ingly, a considerable number of age-regulated miRNAs di-
minish in expression over adult life. This trend is most strik-
ing when considering expression changes during the repro-
ductive phase of early adulthood (days 6-8) or from early to 
mid adult life (days 6-11). Expression of about two thirds of 
the age-related miRNAs (32/50 p0.1; 23/34 p0.05) dimin-
ishes during the reproductive stage (d6-8) or during the re-
productive to mid-life stage (d6-11). This downregulation is 
not likely to be solely attributed to germ cell production 
since germ cell proliferation would increase miRNA abun-
dance, and because many of the miRNAs that change with 
age do not appear to be germline expressed in published 
studies. Expression of most of these age-regulated miRNAs 
is similar in wild-type and young glp-4(bn2) mutant adults 
that lack most germline cells [44], indicating that expression 
changes most likely reflect modulation in the adult soma 
rather than the lack of developing embryos in the spe-9 mu-
tant (our study used mutations to block fertilization so em-
bryonic development cannot contribute). That there appears 
to be a general down-regulation of miRNAs suggests that a 
relaxation in precise transcriptional/translational controls 
might be a general feature of advancing adult life in C. ele-
gans. It is conceivable that a modest dysregulation of protein 
synthesis could initiate declines in multiple systems during 
adulthood. This hypothesis remains to be tested, beginning 
with whole-genome analysis of proteomic consequences of 
miRNA decline. 
  One can speculate that specific patterns of expression 
might identify miRNAs that exert specific influences on the 
biology of aging. For example, miRNAs that decline early in 
adult life might be associated with, or possibly even causal 
in, “mid-life” crises in metabolism such as the transition to 
increased rates of age pigment/lipofuscin accumulation or 
the onset of sarcopenia [6, 14]. The miRNAs that exhibit 
highest or lowest levels at the end of life (see Fig. 1D-E and 
Suppl. Fig. S2 in [48] for a list of 25 that exhibit greatest 
changes at the last sampling time) could reflect two alterna-
tive situations. On the one hand, on the last sampling day (15 
days), 93% of animals have already died and the animals that 
are still viable are all in the most decrepit stage of life. Thus, 
the miRNA profile at this point might best reflect the end-
stage, extremely aged animal. Alternatively, one could note 
that the surviving 7% of the population have lived longer 
than most of the culture and thus they might express a 
miRNA profile more typical of the most robust animals in a 
given culture—the C. elegans equivalent of centenarians. If 
any of the late-changing miRNAs identified are causative in 
end-stage aging biology, these two models might be experi-
mentally addressed by testing consequences of deletion or 
over-expression of miRNAs that change the most at the day  
 
15 timepoint. Finally, one might wonder about the miRNAs 
with greatest changes in relative abundance over adult life. 
One miRNA, conserved miR-231 (Fig. 1C), stands out as the 
most abundant age-regulated C. elegans miRNA (highest 
levels at day 15) with the largest net increase (~11-fold) and 
greatest variation over adulthood (big increase to day 11, 
sharp decrease at day 13 and strong increase at day 15). miR-
231, and other miRNAs that change with age, might impact 
expression of gene batteries that modulate lifespan or the 
quality of aging, a general hypothesis that can be tested with 
the powerful research tools that can be applied in this model. 
We list age-regulated C. elegans miRNAs exhibiting largest 
changes in expression in (i) early adulthood, (ii) late adult-
hood or (iii) over adult life in Table 2. 
MicroRNA  lin-4 MODULATES THE QUALITY OF 
AGING AND THE LIFESPAN OF C. elegans 
  A key question is to what extent miRNAs influence the 
biology of healthy aging and lifespan in a given organism 
and across species. It has been proposed that miRNAs func-
tion in biology to insure developmental robustness and main-
tain homeostasis [55]. Since aging has been described as a 
progressive loss of robustness and stress resistance, a logical 
corollary is that miRNA changes during adult life might 
limit robustness and contribute to aging. Analysis of lin-4 
impact on aging [56] is the first example of a miRNA that 
plays a defined role in normal development and also modu-
lates both healthspan and lifespan. 
 During  development,  C. elegans lin-4 binds to 3’ UTR 
sequences of the lin-14 mRNA to downregulate expression 
of the transcription factor LIN-14, enabling specification of 
hypodermal cell fate transition from the first to the second 
larval stage [57] (Fig. 2A). With regard to adult phenotypes, 
lin-4 loss-of-function (lf) shortens lifespan, whereas over-
expression of lin-4 lengthens lifespan (Fig. 2B-C). Long life 
is associated with lowered levels of age pigment accumula-
tion and increased heat stress resistance, suggesting that not 
just lifespan, but also healthspan is modulated by the lin-4 
miRNA. In support of a normal role for lin-4 in healthspan 
promotion, we have also observed accelerated locomotory 
decline in middle-age lin-4(lf) mutants (C.I-V, MV and MD 
unpublished observations). lin-4 requires the presence of 
target lin-14 to exert its effects in adult life, with lin-14(gf) (a 
mutant that lacks the lin-4 binding sites in the 3’UTR) mim-
icking the deleterious effects of lin-4(lf) [56]. Together, these 
observations suggest that normal lin-4 function in adult life 
limits pro-aging effects of lin-14. Since lin-4 is one of the 
miRNAs that decline in abundance with age, we could 
speculate that as lin-4 levels diminish during adult life, ele-
vated expression of lin-14 occurs in aging animals with dele-
terious consequences for the quality of aging (Fig. 2D). This 
may be a good example of antagonistic pleiotropy in which a 
gene that confers developmental benefit is actually deleteri-
ous later in life [58]. 
 How  does  lin-14 promote age-associated decline? lin-
14(lf) does not extend lifespan without the critical down-
stream transcription factors of insulin signaling FOXO/DAF-
16 or HSF-1, suggesting that lin-14 modulates the level of 
insulin signaling, a well characterized mechanism for modu-
lation of lifespan (Fig. 2E).  148    Current Genomics, 2009, Vol. 10, No. 3  Ibáñez-Ventoso and Driscoll 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Representative miRNA expression profiles over C. elegans adult life. 
A: Lifespan of C. elegans spe-9(hc88) in one representative sample collection for small RNA isolation (n=60, 25.5 ºC). Time 0 corre-
sponds to harvest of eggs and reproductive period extends over days ~3-7 (judged from laying of unfertilized oocytes in this fertility mutant). 
Small RNA samples were prepared from days marked by downward arrows (days 4, 6, 8, 11, 13 and 15). 
B: Expression of conserved microRNAs let-7, lin-4 and miR-1 over adult life. Expression levels are normalized to the levels measured at 
day 4, the first day of adult life. A downward trend in expression is typical of most age-regulated miRNAs. 
C: Expression of microRNA miR-231 over adult life. Expression levels are normalized to the levels measured at day 4. miR-231 is one of a 
few age-regulated miRNAs that generally increases with age and is also the most abundantly expressed. It might be noteworthy that the 25% 
survival point of 13 days often appears to be a transition point in expression profiles for individual miRNAs. 
D: microRNAs showing highest expression late in life (day 15) from the 95% confidence group of 34 age-regulated microRNAs. Ex-
pression levels are normalized to the levels measured at day 4. miR-231 (Fig. 1C) also shows greatest expression on day 15. 
E: microRNAs showing lowest expression late in life (day 15) from the 95% confidence group of 34 age-regulated microRNAs. Ex-
pression levels are normalized to the levels measured at day 4. MicroRNAs in C. elegans Aging  Current Genomics, 2009, Vol. 10, No. 3    149 
Table 2.  MicroRNAs that Dramatically Change in Expression Levels Early (i), Late (ii) or Over (iii) C. elegans Adult Life (95% 
Confidence Statistic) 
Expression Levels 
Adult Stage 
(A) Increase  (B) Decrease 
(i) Early   miR-34   let-7, miR-36, miR-42, miR-59, miR-77 
(ii) Late   miR-231, miR-243, miR-251, miR-268, miR-358   miR-41, miR-42, miR-70, miR-77, miR-229 
(iii) Over Adulthood  miR-34, miR-231, miR-243, miR-251, miR-268  miR-42, miR-70, miR-77, miR-229, miR-273 
miRNAs with largest increases or decreases in each indicated stage of adult life are included in columns (A) and (B), respectively. miRNAs within a group are listed in numerical 
order. Bold miRNAs with homologous sequences among human miRNAs (see Table 1 and [32] for specific details on the sequence conservation). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Summary of microRNA lin-4 and target lin-14 relationships in developmental cell fate specification and in longevity. 
A: Representative schematic of lin-4_lin-14 interaction with regard to their expression changes during early larval development. The 
miRNA lin-4 increases in expression level at the end of the first larval stage (L1), when it down-regulates expression of lin-14 transcript and 
consequently LIN-14 protein to allow second larval stage (L2) cell fates to occur. For depicted lin-14 transcript, box indicates coding region 
and flanking lines indicate UTRs. Only one of the seven lin-4 complementary sites in the 3’ UTR of the lin-14 transcript is shown. 
B-C: Survival trends of lin-4 loss-of-function (lf) mutant (B) and lin-4 over-expressing transgenic (o.t.) (C) compared to those of wild 
type (wt). Please refer to [56] for actual graphs and data. 
D: Proposed lin-4_LIN-14 expression relationship during adulthood. lin-4 miRNA levels fall during midlife, which could increase ex-
pression of LIN-14 protein. 
E: Diagram summary of lin-4_LIN-14 effect on longevity through FOXO/DAF-16 and HSF-1. Low levels of lin-14 expression allow 
enhanced expression of lifespan-promoting FOXO/DAF-16 and HSF-1 transcription factors [56]. 150    Current Genomics, 2009, Vol. 10, No. 3  Ibáñez-Ventoso and Driscoll 
 
ROLES OF OTHER C. elegans MicroRNAs IN AGING 
 Many  C. elegans mir genes have been knocked out, in-
cluding 87 deleted in one massive screen [38]. Interestingly, 
the majority of these mir deletion mutants did not exhibit 
lethality or major phenotypic changes in developmental tim-
ing, mobility, gross morphology and reproduction. One pos-
sible explanation is that there could be a considerable amount 
of functional redundancy among sequence-related or other 
miRNAs. As noted above, there is strong experimental evi-
dence for functional redundancy for the let-7 family [33, 36], 
and many C. elegans miRNAs share potential for functional 
redundancy [32]. It is also possible that miRNAs primarily 
modulate protein expression levels such that the conse-
quences of their individual disruption are not dramatic. Apart 
from the elegant lin-4 investigations on lifespan [56], there 
are no published reports yet on roles of other C. elegans 
miRNAs on lifespan and healthspan. Although much care-
fully controlled work remains to be done, a first pass look at 
age-associated phenotypes in several mir mutants suggests 
that multiple miRNAs may prove to promote healthspan (CI-
V, MV, SG, MS, DZ and MD, unpublished observations), 
consistent with the hypothesis that this gene class may con-
tribute to robustness required for maintenance of healthspan. 
If this proves to be the case, the C. elegans model will be an 
important proving ground for genetic miRNA “therapies” 
that might promote healthy aging in transgenic studies. 
WHAT ARE THE TRANSCRIPTS IMPACTED BY 
AGE-REGULATED MicroRNAs?—THE CHALLENGE 
OF TARGET PREDICTIONS 
  Central to the understanding of miRNA impact on aging 
will be the identification of physiologically relevant targets. 
The expectation is that a highly complex web of miRNA 
interactions must exist, given that individual transcripts can 
be targeted by multiple miRNAs and that individual   
miRNAs can interact with multiple transcripts. In the ab-
sence of quantitative, cell-specific biochemical identification 
of miRNA-targeted transcripts, computational target predic-
tions have been generated to suggest the arrays of mRNA 
transcripts that might be subjected to regulation by specific 
miRNAs (e.g. [48, 53, 59, 60]). It should be underscored that 
different target prediction algorithms do not necessarily pre-
dict the same target lists, although programs are continu-
ously being improved based on accumulating experimental 
data [61, 62]. Thus, the predictions are taken to suggest po-
tential targets, but few targets have been experimentally veri-
fied and modeling based on these predictions should be ex-
tremely cautious until verifications are established. 
  We used an algorithm described in [63] to search all pre-
dicted C. elegans transcripts for 3’ UTR target sites of the 50 
age-regulated miRNAs (Suppl. Table 2 in [48]). We also 
generated specific target group lists to ask whether, in prin-
ciple, the age-regulated miRNAs might preferentially target 
genes previously implicated in longevity, or to identify po-
tential mRNA targets of interest for aging biology. For ex-
ample, we screened a list of more than 200 genes known to 
influence  C. elegans lifespan (referred to as gerontogenes; 
204 listed in Suppl. Table S3 of [48]) to identify 42/204 ger-
ontogenes that have predicted 3’UTR binding sites for age-
regulated miRNAs. Conversely, we find 31/50 age-regulated 
miRNAs are predicted as candidate modulators of these ger-
ontogenes. When we considered the group of genes involved 
in insulin signaling, we found that age-regulated miRNAs 
might target 14/39 insulin transcripts and that 11 of the 50 
age-regulated miRNAs potentially target insulin genes. We 
list the gerontogenes and insulin genes that have multiple 
predicted sites for age-regulated miRNAs in Table 3 (see [48] 
for total lists; miRNA lin-4 influences aging through regula-
tion of 7 sites in the 3’ UTR of the gene lin-14 [56, 57, 64]). 
  Computational strategies such as these can highlight spe-
cific miRNAs for experimental investigations of tissue-
specific age-related declines. For example, with an interest in 
identifying miRNAs that might impact muscle aging, we 
searched a list of genes expressed preferentially in muscle 
[65] for 3’ UTR sites that might bind age-regulated miRNAs. 
We found that of 1364 muscle-enriched genes, 232 have 
potential 3’ UTR binding sites for age-regulated miRNAs. 
Age-regulated miR-1 (17), miR-268 (38), and miR-85 (31) 
have the most predicted targets in the muscle-enriched gene 
list and thus could be prioritized for testing for roles in sar-
copenia. 
MicroRNA CHANGES IN MAMMALIAN MODELS 
OF AGING 
  Gigantic strides have been accomplished in the under-
standing of miRNA biogenesis and in deciphering mecha-
nisms of miRNA regulation of cellular processes during de-
velopment, health and pathology. Mammalian miRNA pro-
files in the areas of diseases of aging such as cancer [66] and 
neurodegeneration [67] have been reported. The investiga-
tion of miRNAs in aging and age-related diseases is just be-
ginning to come into focus--analyses of miRNAs in aging 
muscle [68], liver [69], and brain [70] have been recently 
published to highlight miRNA expression changes during 
adult life; by contrast, miRNAs in aging lung do not appear 
to change [71]. Already, studies in aging subjects have pro-
vided unexpected insights into miRNA regulation in older 
animals. For example, analysis of miRNA profiles in exer-
cised skeletal muscle [68] suggests that aging might be cor-
related with differences in precursor, rather than mature, 
miRNA levels, a fact that might have physiological conse-
quences. 
  At present, it is probably premature to compare mammal-
ian tissue-specific studies to whole animal surveys in C. ele-
gans. However, intriguing potential connections have begun 
to appear. For example, it is tantalizing that in mammalian 
cells, miR-34 elevation is associated with p53-induced cell 
senescence [72, 73] and C. elegans miR-34 is one of the few 
miRNAs that increase in abundance with age [48]. Hypothe-
ses regarding potential miR-34 roles in promoting senes-
cence in C. elegans could easily be tested given reagents 
available in this facile model. In the future, key advances in 
cataloging age-regulated miRNAs in mammalian tissues 
should be compared with studies of roles of C. elegans 
miRNAs in analogous tissues to begin to address whether 
conserved miRNA-regulated processes relevant to aging 
biology might exist. 
PERSPECTIVES 
  In this review we have emphasized how basic characteri-
zation of miRNAs in C. elegans converge with extensive MicroRNAs in C. elegans Aging  Current Genomics, 2009, Vol. 10, No. 3    151 
lifespan and healthspan studies conducted in this model to 
date to set up a powerful system for the experimental evalua-
tion of roles of miRNAs in the biology of aging of a single 
organism. We know that there are significant changes in 
miRNA abundance during adult life that occur in various 
“patterns” (with nearly 50% of 114 tested miRNAs modu-
lated) and the elegant lin-4 study from Bohem and Slack [56] 
serves as a proof-of-principle example that a single con-
served miRNA can modulate lifespan and healthspan. Major 
questions, however, remain to be addressed. We have sug-
gested that miRNAs contribute to the robustness of the ani-
mal and that the general decline in miRNA levels that is ap-
parent when expression in all tissues is averaged over adult 
life might contribute to age-associated deterioration and dys-
function. How broadly miRNAs are implicated in lifespan 
and healthspan modulation can now be addressed in the 
nematode model by systematic evaluation of lifespan and 
healthspan indicators in mir mutants and in lines that over-
express individual mir genes. It will be particularly impor-
tant to determine whether there a few key “node” miRNAs 
that regulate large networks of genes that impact aging, such 
as oxidative stress response networks, metabolic pathways, 
and insulin signaling pathways. Defining such node miRNA 
regulators of aging biology will hold particular significance 
if they exert conserved roles in mammalian healthspan. 
  It is also possible that specific miRNA levels in adult life 
have potential to be used as diagnostics for scoring “physio-
logical” (rather than chronological) age as is the case for age 
pigment levels in C. elegans [14]. Comparisons of miRNA 
profiles in animals that age well vs those that age poorly 
might indicate expression patterns correlated with strong 
healthspan. Given the suggestion that miRNA changes in 
midlife might underlie some of the early pre-clinical changes 
that ultimately manifest as age-associated decline [74], it 
should be possible to address this hypothesis by genetic ma-
nipulations of miRNAs that change midlife in the nematode 
model. 
 Finally,  the  C. elegans model might also be used to ad-
dress how well genetic interventions using miRNAs can be 
used to extend healthy life phases. Genetic engineering or 
direct miRNA administration that modifies miRNA expres-
sion time or level can be conducted to address basic princi-
ples regarding small molecular therapeutics that promote 
healthy aging. Our initial impression is that whole life over-
expression of individual mir genes may not be easily toler-
ated by the animal (disruption of balance in developmental 
roles might be deleterious)—however, late life expres-
sion/administration, more relevant to potential clinical appli-
cation, remains to be evaluated. Success will support conjec-
ture that miRNA modulation might have therapeutic value 
[75, 76] in mid and late life to improve human healthspan. 
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